Nicergoline

MECHANISM OF ACTION

Nicergoline works by blocking α1-adrenergic receptors, causing dilation of cerebral blood vessels and improving blood flow to the brain. It also enhances oxygen and glucose utilization in brain cells and supports neurotransmitter activity, which helps improve cognition and memory.

PHARMACOKINETICS

Absorption

Nicergoline is well absorbed after oral administration, but it undergoes extensive first-pass metabolism in the liver, which reduces the amount of unchanged drug reaching systemic circulation. Food may slightly delay absorption but does not significantly affect overall bioavailability. After absorption, it is rapidly metabolized into active metabolites that contribute to its therapeutic effects on cerebral blood flow and metabolism.

Distribution

Nicergoline is widely distributed in body tissues after absorption, with good penetration into the central nervous system due to its lipophilic nature. It shows moderate to high plasma protein binding, and both the parent drug and its active metabolites contribute to its distribution in cerebral tissues, where it exerts its pharmacological effects on blood flow and metabolism.

Metabolism

Nicergoline is extensively metabolized in the liver after absorption, mainly through hydrolysis and demethylation reactions. It is converted into several active metabolites, which contribute significantly to its therapeutic effects. Hepatic metabolism plays a major role in its clearance, and the process results in metabolites that are further processed before excretion.

Elimination

Nicergoline is eliminated mainly through the kidneys as metabolites, with a smaller portion excreted in feces via bile. The parent drug is present only in minimal amounts in urine because it undergoes extensive hepatic metabolism. Its elimination half-life is relatively short, but the effects may persist longer due to active metabolites.

PHARMACODYNAMICS

Nicergoline works mainly by blocking α1-adrenergic receptors, causing vasodilation and improving cerebral blood flow. It also enhances oxygen and glucose use in the brain and modulates neurotransmitters like dopamine and acetylcholine, which helps improve cognition and memory.

ADMINISTRATION

Nicergoline is administered orally, usually in tablet form. It is taken 2–3 times daily depending on the prescribed dose and the condition being treated, often recommended before meals for better absorption. The dosage is adjusted based on patient response and clinical indication, particularly in chronic cerebral insufficiency or cognitive impairment.

DOSAGE AND STRENGTH

Nicergoline is commonly available in oral tablet form with strengths of 5 mg, 10 mg, and 30 mg depending on the manufacturer and country. The usual adult dosage ranges from 5–10 mg taken 2–3 times daily, or in some regimens 30 mg once or twice daily, depending on the condition being treated and patient response. Dosage is typically adjusted gradually based on therapeutic effect and tolerance.

DRUG INTERACTIONS

Nicergoline may interact with antihypertensive drugs by enhancing blood pressure–lowering effects, leading to hypotension. It can also increase bleeding risk when combined with anticoagulants or antiplatelet agents. Caution is advised with CNS-active drugs, as they may alter its central effects, and with sympathomimetics, which may reduce its vasodilatory action.

FOOD INTERACTIONS

Nicergoline has minimal food interactions and can generally be taken with or without food. However, taking it with meals may help reduce gastrointestinal side effects such as nausea or stomach discomfort in some patients. No specific food is known to significantly alter its absorption or effectiveness.

CONTRAINDICATIONS

Nicergoline is contraindicated in patients with known hypersensitivity to nicergoline or other ergot derivatives. It should be avoided in patients with recent myocardial infarction, severe bradycardia, or acute hemorrhage due to its vasodilatory and platelet effects. It is also contraindicated in patients with severe hypotension or orthostatic hypotension, as it may further lower blood pressure and worsen symptoms.

SIDE EFFECTS

• Headache 

• Dizziness 

• Flushing 

• Nausea 

• Abdominal discomfort 

OVER DOSAGE

• Severe hypotension 

• Dizziness 

• Headache 

• Flushing 

• Tachycardia (reflex)

TOXICITY

Nicergoline toxicity is uncommon but results from excessive vasodilatory and central nervous system effects. It may present with severe hypotension, marked dizziness, flushing, reflex tachycardia, nausea, vomiting, and syncope. In more serious cases, confusion, collapse, or circulatory instability can occur. Management is mainly supportive, including discontinuation of the drug, monitoring of vital signs, and symptomatic treatment.